期刊文献+

类风湿关节炎患者血脂水平与疾病活动度的相关性研究 被引量:5

Correlation between Levels of Lipid Profile and Disease Activity in Rheumatoid Arthritis
原文传递
导出
摘要 目的:观察类风湿关节炎(RA)患者血脂的变化,以及血脂水平与疾病活动度之间的相关性。方法:对71例RA患者和77例正常对照的血脂水平进行回顾性分析,并对RA患者的血脂水平与其疾病活动度进行相关性分析。结果:RA患者的血清总胆固醇(TC)、甘油三酯(TG)水平均高于正常对照组(P<0.01),高密度脂蛋白(HDL)水平降低(P<0.01)。DAS28评分与TC(r=0.49,P<0.01)、TG(r=0.38,P<0.01)和LDL(r=0.55,P<0.01)呈正相关,与HDL呈负相关(r=-0.57,P<0.01),血沉与TC(r=0.26,P=0.03)、TG(r=0.28,P=0.02)呈正相关,C反应蛋白与TC(r=0.65,P<0.01)、TG(r=0.30,P=0.01)和LDL(r=0.39,P<0.01)均呈正相关。结论:RA患者存在血脂水平异常,且与疾病活动度相关。对血脂进行干预可能改善RA患者的长期预后。 Objective: To observe the changes ofserum lipids in rheumatoid arthritis(RA) patients and its correlation with the activity of this disease. Methods: This study was done on 71 RA patients and 77 normal controls. The lipid profile, ESR, CRP and DAS28 index were recorded by retrospective analysis. The correlation of lipid profile and disease activity was analyzed. Results: Compared with normal control group, the levels of total cholesterol(TC) and triglyceride(TG) in RA group were higher significantly(P〈0.01), HDL level was lower(P〈0.01). DAS28 index was correlated with the levels of TC(r=0.49, P〈0.01), TG(r=0.38, P〈0.01), LDL(r=0.55, P〈0.01) and HDL(r=-0.57, P〈0.01). ESR was positively correlated with TC(r=0.26, P=0.03) and TG(r=0.28, P=0.02); and CRP was positively correlated with TC(r=0.65, P〈0.01), TG(r=0.30, P=0.01) and LDL(r=0.39, P〈0.01). Conclusions: Dyslipidaemia was existed in RA patients and correlated with disease activity. The management of dyslipidaemia may improve the long-term outcomes in RApatients.
出处 《现代生物医学进展》 CAS 2016年第1期103-105,共3页 Progress in Modern Biomedicine
基金 四川省卫生厅科研项目(130320 130322) 成都军区总医院院管课题(2013YG-B037 2013YG-B096)
关键词 类风湿关节炎 血脂异常 疾病活动度 回顾性研究 Rheumatoid arthritis Dyslipidaemia Disease activity Retrospective study
  • 相关文献

参考文献20

  • 1GhoshUC, Roy A, Sen K, et al. Dyslipidcmia in rheumatoid arthritis in a tertiary care center in Eastern India: a non-randomised trial[J]. J Indian Med Assoc, 2009, 107(7): 427-430.
  • 2Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis[J]. Am J Med, 2008, 121 (10 Suppl 1): S9-14.
  • 3Libby P, Ridker PM, Maseri A. Inflammation and atherosclvrosis [J].Circulation, 2002, 105 (9): 1135-1143.
  • 4Solomon DH, Kremer J, Curtis JR, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markars of rheumatoid arthritis severity [J]. Ann Rheum Dis, 2010, 69(11): 1920-1925.
  • 5Maradait-KrcmcrsH, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population based study [J]. Arthritis Rheum, 2005, 52(3): 722-732.
  • 6Myasoedova E, Crowson CS, Kremers HM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease [J]. Ann Rheum Dis, 2011, 70(3): 482-487.
  • 7Sattar N, McCarey DW, Capell H, et al, Explaining how "High-Grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis[J]. Circulation, 2003, 108(24): 2957-2963.
  • 8Zhang J, Chen L, Delzell E, et al. The association between inflammatory markers, sorum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis [J]. Ann Rheum Dis, 2014, 73 (7): 1301-1308.
  • 9Vottery R, Saigal R, Singhal N, et al. Lipid profile in rheumatoid arthritis and its relation to disease activity[J]. JAssoc Physicians India, !2001, 49:1188-1190.
  • 10Grover S, Sinha RP, Singh U, et al. Subclinical atbcrosclerosis in rheumatoid arthritis in India[J]. The Journal of Rheumatology, 2006, 33 (2): 244-247.

二级参考文献10

  • 1Hahn BH, Grossman J, Ansell BJ, et al. Altered lipoproteln metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther, 2008,10:213.
  • 2McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum, 2006,54:2541-2549.
  • 3Gonzalez A, Maradit Kremers H, Crowson CS, et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis, 2008 ,67:64-69.
  • 4Nurmohamed MT. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag, 2007,3:845-852.
  • 5Brady SR,deCourten B, Reid CM, et al. The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol, 2009, 36: 34 -40.
  • 6Salmon JE,Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med, 2008,121:3-8.
  • 7Forrester SJ, Makkar R, Shah PK. Increasing high- density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition. Circulation, 2005,111 : 1847-1854.
  • 8Pereira I, Laurindo I, Burlingame R, et al. Auto- antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis . Joint Bone Spine, 2008,75:416-421.
  • 9Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med, 2008 ,121:9-14.
  • 10Maradit Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population based study. Arthritis Rheum, 2005 ,52:722-732.

共引文献6

同被引文献28

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部